logo
Fear and mistrust in Chinese town where more than 200 children poisoned by lead in their food

Fear and mistrust in Chinese town where more than 200 children poisoned by lead in their food

Yahoo12-07-2025
Taped doors and quiet rooms tell a story about what happened at Heshi Peixin kindergarten.
A huge scandal in a tiny town, a barely believable failing, in a place where children should have been safe.
As soon as we arrive in the northwestern Chinese town of Maiji, it is clear that almost everyone knows someone who has been impacted.
After multiple children were found to have high levels of lead in their blood, police say staff at the private kindergarten had been adding paint powder to food in an apparent bid to make it look more appealing.
A total of 233 of the 251 children had unhealthy levels and 201 needed to be hospitalised, say local authorities.
Two food samples were seized and both had lead levels 2000 times the legal safe limit.
Eight people have been arrested, including the principal and the kindergarten's financial backer.
On one street in this town, a series of shops sell clothes and goods for babies and toddlers. The women who work there all knew the principal and many of the families affected. One even used to work there.
They tell us how distressing it's been for the community.
One lady whispers with tears in her eyes about how a neighbour's child was found to have lead in her blood at 38 times the normal level.
Lead poisoning at this level could cause long term injuries for the brain and the central nervous system.
What surprises us is how the kindergarten and its staff are by far the sole focus of their anger.
In fact more than one person speaks fondly of the principal, citing her extensive charity work and dedication to children.
There might have been huge failings at Heshi Peixin, but here they clearly feel there are failings in the system too.
Indeed, most affected families have chosen to leave here to seek treatment in major cities, mainly in Xi'an, the closest major city, which is a four-hour drive away.
We are told multiple times that the local hospital returned tests for lead showing much lower levels than at the bigger hospitals.
'This is a cover up'
On the street corners, it's all they are discussing, tapping into veins of distrust.
"I don't know much, but I think this is a cover up," says one woman who we meet at the side of the road. "I just think local government is too dark, they suppress the news."
Another young mother talks about how she lived just around the corner from the kindergarten.
"Who will be willing to have children? Who dares to send the children to kindergarten?" she asks.
"Now if people send children to primary school, the first thing they ask is are you safe? Is the school safe? Can it guarantee the personal safety of our children in the future, right?"
There is no clear evidence of a cover-up, but it's telling that it's what people expect.
There is clear anxiety about the fact we are here. The police intercept us and hold us up for over an hour. And perhaps that is no surprise because in China a history of food safety scandals is a sore point.
Read more from Sky News:Air India crash preliminary report released'At least 798 killed' at Gaza aid points
Cooking oil was last year found to be being transported in containers used for fuel without proper cleaning in between.
And most famously, in 2008, milk powder laced with the chemical melamine, left six children dead and hundreds of thousands unwell.
Food scandals here are a source of real rage and resentment, dangerous things for a government that people cannot choose.
Cases like this are just a glimpse into how deep that frustration can run.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Plans to list etomidate as illegal drug: Ong Ye Kung, Typhoon Wipha causes major flight disruptions: Singapore live news
Plans to list etomidate as illegal drug: Ong Ye Kung, Typhoon Wipha causes major flight disruptions: Singapore live news

Yahoo

time4 hours ago

  • Yahoo

Plans to list etomidate as illegal drug: Ong Ye Kung, Typhoon Wipha causes major flight disruptions: Singapore live news

Singapore's Health and Home Affairs Ministries are working to list etomidate, which is being abused via e-vaporisers, under the Misuse of Drugs Act (MDA), Health Minister Ong Ye Kung said on Sunday (20 July). This paves the way for abusers and traffickers of Kpods – vapes containing etomidate – to be treated in the same way as those who abuse or traffic drugs like nimetazepam (Erimin-5), with mandatory rehabilitation and jail time for repeat offenders. Currently, etomidate is listed under the Poisons Act. Under this law, abusers face only a fine. Sellers face possible jail time of up to two years. Ong said this will be done in the coming weeks. He added that it will be an interim measure until further changes can be made to the law to tackle the vaping scourge in Singapore. Read more about why there are plans to list etomidate under the MDA. Typhoon Wipha toppled trees and caused major flight disruptions Sunday (20 July) in Hong Kong and at some nearby airports in China as it moved west off the southern coast of the country. Earlier on Sunday morning, the Hong Kong Observatory issued a hurricane signal No. 10, its highest warning. Find out more about Typhoon Wipha, which was later downgraded to a severe tropical storm. Read more in our live blog below, including the latest local and international news and updates: MOH, MHA working to list etomidate as illegal drug: Ong Ye Kung Singapore's Health and Home Affairs Ministries are working to list etomidate, which is being abused via e-vaporisers, under the Misuse of Drugs Act (MDA), Health Minister Ong Ye Kung said on Sunday (20 July). This paves the way for abusers and traffickers of Kpods – vapes containing etomidate – to be treated in the same way as those who abuse or traffic drugs like nimetazepam (Erimin-5), with mandatory rehabilitation and jail time for repeat offenders. Currently, etomidate is listed under the Poisons Act. Under this law, abusers face only a fine. Sellers face possible jail time of up to two years. Ong said this will be done in the coming weeks. He added that it will be an interim measure until further changes can be made to the law to tackle the vaping scourge in Singapore. Read more about why there are plans to list etomidate under the MDA. Typhoon Wipha causes damage, disrupt flights, before weakening to severe tropical storm Typhoon Wipha toppled trees and caused major flight disruptions Sunday (20 July) in Hong Kong and at some nearby airports in China as it moved west off the southern coast of the country. Earlier on Sunday morning, the Hong Kong Observatory issued a hurricane signal No. 10, its highest warning. Airports in Hong Kong, Shenzhen, Zhuhai and the casino hub of Macao canceled or postponed flights for most of the day, according to their websites. Hong Kong grounded at least 400 flights, affecting around 80,000 passengers, broadcaster RTHK said. Some high-speed train services were also suspended. The typhoon stayed just offshore until about 6 pm, when it made landfall in a coastal area of Taishan city in Guangdong province, China's National Meteorological Center said. It then weakened to a severe tropical storm with maximum sustained winds of 108 kph. Singapore's Health and Home Affairs Ministries are working to list etomidate, which is being abused via e-vaporisers, under the Misuse of Drugs Act (MDA), Health Minister Ong Ye Kung said on Sunday (20 July). This paves the way for abusers and traffickers of Kpods – vapes containing etomidate – to be treated in the same way as those who abuse or traffic drugs like nimetazepam (Erimin-5), with mandatory rehabilitation and jail time for repeat offenders. Currently, etomidate is listed under the Poisons Act. Under this law, abusers face only a fine. Sellers face possible jail time of up to two years. Ong said this will be done in the coming weeks. He added that it will be an interim measure until further changes can be made to the law to tackle the vaping scourge in Singapore. Read more about why there are plans to list etomidate under the MDA. Typhoon Wipha causes damage, disrupt flights, before weakening to severe tropical storm Typhoon Wipha toppled trees and caused major flight disruptions Sunday (20 July) in Hong Kong and at some nearby airports in China as it moved west off the southern coast of the country. Earlier on Sunday morning, the Hong Kong Observatory issued a hurricane signal No. 10, its highest warning. Airports in Hong Kong, Shenzhen, Zhuhai and the casino hub of Macao canceled or postponed flights for most of the day, according to their websites. Hong Kong grounded at least 400 flights, affecting around 80,000 passengers, broadcaster RTHK said. Some high-speed train services were also suspended. The typhoon stayed just offshore until about 6 pm, when it made landfall in a coastal area of Taishan city in Guangdong province, China's National Meteorological Center said. It then weakened to a severe tropical storm with maximum sustained winds of 108 kph. Typhoon Wipha toppled trees and caused major flight disruptions Sunday (20 July) in Hong Kong and at some nearby airports in China as it moved west off the southern coast of the country. Earlier on Sunday morning, the Hong Kong Observatory issued a hurricane signal No. 10, its highest warning. Airports in Hong Kong, Shenzhen, Zhuhai and the casino hub of Macao canceled or postponed flights for most of the day, according to their websites. Hong Kong grounded at least 400 flights, affecting around 80,000 passengers, broadcaster RTHK said. Some high-speed train services were also suspended. The typhoon stayed just offshore until about 6 pm, when it made landfall in a coastal area of Taishan city in Guangdong province, China's National Meteorological Center said. It then weakened to a severe tropical storm with maximum sustained winds of 108 kph.

Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management
Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management

Yahoo

time6 hours ago

  • Yahoo

Fangzhou and Novo Nordisk Signed Collaboration Memorandum to Establish a New Ecosystem for Health Management

BEIJING, July 21, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") ( a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and and Novo Nordisk Signed Collaboration Memorandum Fangzhou's founder, chairman, and CEO Dr. Xie Fangmin, and Christine Zhou, Novo Nordisk Senior Vice President & President of Region China, attended the signing ceremony. By leveraging Novo Nordisk's expertise and innovative products in diabetes and obesity treatment, Fangzhou plans to employ its smart healthcare ecosystem and robust technology infrastructure to create a comprehensive health management service. This will include medication guidance, reminders, efficacy tracking, and health education, effectively shaping the value chain in the glucose control and weight loss sector. The aim is to shift the focus from a 'disease-centered' approach to a 'health-centered' model, providing patients with higher quality and more convenient one-stop healthcare services. Dr. Xie Fangmin remarked, 'We are partnering with Novo Nordisk, a leading global healthcare company, to explore AI technology and address the pain points of traditional health management. Together, we aim to deliver innovative digital solutions for managing blood sugar and weight on a global scale.' Christine Zhou said, 'With the combined strengths of both companies, this collaboration will closely integrate chronic disease prevention and digital innovation technology, jointly enhancing public awareness of diabetes and obesity. It will also support the aim that the concepts of early screening, early diagnosis, and early treatment are effectively implemented within smart healthcare environments.' Looking forward, both companies expect to explore further innovative collaborations in the medical industry's digital transformation, with the goal of benefiting patients with serious chronic diseases and accelerating the achievement of the 'Healthy China 2030' strategic objectives. About Fangzhou Inc. ( is China's leading online chronic disease management platform, serving 49.2 million registered users and 223,000 physicians (as of December 31, 2024). The Company specializes in delivering tailored medical care and precision medicine solutions. For more information, visit Media ContactFor further inquiries or interviews, please reach out to:Xingwei Zhao, Associate Director of Public Relations Email: pr@ Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements A photo accompanying this announcement is available at in to access your portfolio

China is catching up to the US in brain tech, rivaling firms like Elon Musk's Neuralink
China is catching up to the US in brain tech, rivaling firms like Elon Musk's Neuralink

CNN

time7 hours ago

  • CNN

China is catching up to the US in brain tech, rivaling firms like Elon Musk's Neuralink

'I want to eat' popped up in Chinese characters on a computer at a public hospital in central Beijing. The words were formed from the thoughts of a 67-year-old woman with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, who is unable to speak. The demonstration, captured on video in March by Beijing Radio and Television Station, was part of a clinical trial involving five patients implanted with a coin-sized chip called Beinao-1, a wireless so-called brain computer interface (BCI) – a technology led by scientists in the US, but in which experts say China is quickly catching up. Luo Minmin, director of the Chinese Institute for Brain Research (CIBR) and the chief scientist behind the trial, said there was a 'very strong' need for BCI technology, saying they had been 'overwhelmed' by requests from potential patients. 'The patients were saying that this feels so great, like they can gain or regain the control of (their) muscles,' he told CNN in May during a rare interview at his lab, located an hour's drive away from Beijing Xuanwu Hospital, where the trial took place. Luo said the technology was showing 'high accuracy' in decoding signals from the brains of patients and translating the signals into text speech or machine movements. His team is planning to speed up human trials by implanting chips into 50 to 100 more patients over the next year. 'We are hoping that we can move this process faster,' he said. 'If it's proven to be safe and effective … it can be used clinically across the world.' As of May, Beinao-1 says a total of five patients, the same number as Elon Musk's Neuralink, has its implants. Another US company Synchron, whose investors include Jeff Bezos and Bill Gates, has undergone trials with 10 patients, six in the United States and four in Australia. Maximilian Riesenhuber, a professor of neuroscience at Georgetown University who was not involved in the Beinao trials, told CNN that despite starting later than the US, China is making advances. 'China has definitely shown the ability to not just catch up, but also then be competitive, and now actually to start, also to drive the field in some areas,' he said. 'Excitingly, there's a lot of research activities in both countries, because they've realized the potential in BCI.' According to Precedence Research, a market research firm, the market for brain technology was worth about $2.6 billion last year and is expected to rise to $12.4 billion by 2034. But for both China and the US, this technology is about much more than cash. Chinese leader Xi Jinping has long aimed to turn his country into a science and economic powerhouse. In March, he wrote in state-owned media that the tech industry had become the 'forefront' and 'main battlefield' of global competition. His ambitions have sparked concern in the US, resulting in an ongoing tech war, particularly in the semiconductor industry. CIBR was jointly founded by the Beijing municipal government and several local universities in 2018, about two years after Elon Musk founded Neuralink near San Francisco. In 2023, CIBR incubated a private company named NeuCyber NeuroTech to focus on brain tech products such as Beinao-1. Luo, who is also the startup's chief scientist, gave CNN rare access to the institute in May. For years, he said, the ALS patient, who is in her 60s, was unable to express herself. 'She's awake, she knows what she wants but she could not speak out,' said the scientist, who got his PhD in neuroscience from the University of Pennsylvania and spent nearly a decade in the US. 'Following the implantation, she can now speak simple sentences quite accurately via the system.' All BCI researchers must address the balance between risk and effectiveness. Riensenhuber said most American firms use the more invasive method to place chips inside the dura mater, an outer layer of tissue that covers and protects the brain and spinal cord, in order to capture better signal. But these methods require riskier surgeries. 'It is interesting to see that NeuCyber is apparently able to get enough information even through the dura to allow the decoding of specific words,' he said. The test on the ALS patient, which began in March, marked the Beinao-1 chip's third trial in humans. Those trials made up what the developers described in a press release as 'the world's first batch of semi-invasive implantation of wireless BCI in human brains.' As of May, two more trials have been conducted, for a total of five. Amid rising geopolitical tensions, comparisons between US and Chinese tech breakthroughs are common. Brain computer interface technology first started in the 1970s in the US. Decades later, the Obama Administration launched its 'Brain Initiative' in 2013, investing more than $3 billion to fund over a thousand neuroscience technology projects since, according to the National Institute of Health. Synchron, based in New York, was the first firm to start human trials in July 2021. Three years later, a new BCI system developed at UC Davis Health translated the brain signals of an ALS patient into speech, achieving an accuracy of 97% – the most accurate system of its kind, the university said in a statement. The same year, Musk's company completed its first human trial, enabling the participant to control a computer mouse with a brain implant. China got its start in brain tech only in the 1990s, but it's advancing fast. In 2014, Chinese scientists introduced the idea of a national project on brain tech to match similar efforts in the US and Europe, according to the Ministry of Science and Technology. Two years later, brain tech was mentioned in the country's five-year plan, which outlines China's national priorities and goals. 'Brain science is new in China,' said Lily Lin, a former research assistant at one of China's top neuroscience research units from 2021 to 2023. 'So, it started a bit late, but its speed of development has been faster than other countries. And the country has given a lot of funding to many scientific research units, and this funding is increasing every year.' Last year, the government issued its first ethical guidelines for research in this area. At the local level, municipal governments in Beijing, Shanghai and other major cities have also offered support for brain technology companies from research and clinical trials to commercialization. Riesenhuber and other researchers from Georgetown University published research on China's BCI development in 2024, stating that efforts from Chinese researchers were 'comparable in sophistication' to those in the US and the United Kingdom. 'We found China's non-invasive BCI research to be comparable with that of other scientifically advanced nations and to be working to overcome obstacles to greater fidelity, throughput, and wider use,' according to the issue brief. 'China's invasive BCI research, while historically behind its non-invasive efforts, has picked up the pace and is approaching global standards of sophistication.' Luo, who has worked in both countries, says the US is the 'front-runner' in both invasive and non-invasive brain tech. But, comparing Beinao-1 and Neuralink is like looking at 'apples and oranges,' he added. The two systems differ not only in implant location but also in the type of brain signals recorded, as well as the method of data transmission. The Chinese chip records a wider range of brain areas, with lower precision for each neuron. 'All in all, I don't think these two products are in a competitive or exclusive relationship,' Luo added. 'The jury is still out, and we don't know yet which route will ultimately benefit patients better.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store